When the same combined treatment was applied to NeuT-IFNAR, the therapeutic effect of Sl-IFN was abrogated and the pattern of tumor growth in this mouse strain resembled the one in NeuT mice treated with CTX + Sl-mock (Figure 5B). This evidence concerns the gene IFNAR1 and neoplasm.